Skip to content
  1. Ahluwalia B, Iribarren C, Magnusson MK, Sundin J, Clevers E, Savolainen O, Ross AB, Tornblom H, Simren M, Ohman L. A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome. Cells. 2021;10(6). Epub 20210610. doi: 10.3390/cells10061459. PubMed PMID: 34200772; PMCID: PMC8230381.
  2. Ahluwalia B, Magnusson MK, Bohn L, Storsrud S, Larsson F, Ohman L, Simren M. Aloe barbadensis Mill. extract improves symptoms in IBS patients with diarrhoea: post hoc analysis of two randomized double-blind controlled studies. Therap Adv Gastroenterol. 2021;14:17562848211048133. Epub 20211008. doi: 10.1177/17562848211048133. PubMed PMID: 34646359; PMCID: PMC8504273.
  3. Algera JP, Storsrud S, Lindstrom A, Simren M, Tornblom H. Gluten and fructan intake and their associations with gastrointestinal symptoms in irritable bowel syndrome: A food diary study. Clin Nutr. 2021;40(10):5365-72. Epub 20210909. doi: 10.1016/j.clnu.2021.09.002. PubMed PMID: 34560607.
  4. Ambartsumyan L, Shaffer M, Carlin K, Nurko S. Comparison of longitudinal and radial characteristics of intra-anal pressures using 3D high-definition anorectal manometry between children with anoretal malformations and functional constipation. Neurogastroenterol Motil. 2021;33(2):e13971. Epub 20200909. doi: 10.1111/nmo.13971. PubMed PMID: 32902923.
  5. Azcarate-Peril MA, Roach J, Marsh A, Chey WD, Sandborn WJ, Ritter AJ, Savaiano DA, Klaenhammer TR. A double-blind, 377-subject randomized study identifies Ruminococcus, Coprococcus, Christensenella, and Collinsella as long-term potential key players in the modulation of the gut microbiome of lactose intolerant individuals by galacto-oligosaccharides. Gut Microbes. 2021;13(1):1957536. doi: 10.1080/19490976.2021.1957536. PubMed PMID: 34365905; PMCID: PMC8354614.
  6. Baker JR, Chey WD, Watts L, Armstrong M, Collins K, Lee AA, Dupati A, Menees S, Saad RJ, Harer K, Hasler WL. How the North American Consensus Protocol Affects the Performance of Glucose Breath Testing for Bacterial Overgrowth Versus a Traditional Method. Am J Gastroenterol. 2021;116(4):780-7. doi: 10.14309/ajg.0000000000001110. PubMed PMID: 33982948.
  7. Balbale SN, Cao L, Trivedi I, Stulberg JJ, Suda KJ, Gellad WF, Evans CT, Lambert BL, Jordan N, Keefer LA. High-Dose Opioid Use Among Veterans with Unexplained Gastrointestinal Symptoms Versus Structural Gastrointestinal Diagnoses. Dig Dis Sci. 2021;66(11):3938-50. Epub 20210101. doi: 10.1007/s10620-020-06742-0. PubMed PMID: 33385263; PMCID: PMC8245587.
  8. Balbale SN, Cao L, Trivedi I, Stulberg JJ, Suda KJ, Gellad WF, Evans CT, Lambert BL, Keefer LA, Jordan N. Characteristics of Opioid Prescriptions to Veterans With Chronic Gastrointestinal Symptoms and Disorders Dually Enrolled in the Department of Veterans Affairs and Medicare Part D. Mil Med. 2021;186(9-10):943-50. doi: 10.1093/milmed/usab095. PubMed PMID: 33693755; PMCID: PMC8521668.
  9. Balsiger LM, Tack J. Letter to the editor: prospective, double-blind diagnostic multicentre study of confocal laser endomicroscopy for wheat sensitivity in patients with irritable bowel syndrome. Gut. 2021. Epub 20211110. doi: 10.1136/gutjnl-2021-326252. PubMed PMID: 34759039.
  10. Bar N, Kinaani F, Sperber AD, Amir-Barak H, Dekel R. Low Risk of Neoplasia and Intraprocedural Adverse Events in Gastric Hyperplastic Polypectomy. J Clin Gastroenterol. 2021;55(10):851-5. doi: 10.1097/MCG.0000000000001446. PubMed PMID: 33060440.
  11. Basnayake C, Geeraerts A, Pauwels A, Koek G, Vaezi M, Vanuytsel T, Tack J. Systematic review: duodenogastroesophageal (biliary) reflux prevalence, symptoms, oesophageal lesions and treatment. Aliment Pharmacol Ther. 2021;54(6):755-78. Epub 20210727. doi: 10.1111/apt.16533. PubMed PMID: 34313333.
  12. Beinvogl B, Cohen A, DiFilippo C, Kane M, Nurko S, Rosen R. Impact of Coronavirus Disease 2019 on the Pediatric Population with Aerodigestive Disease. J Pediatr. 2021. Epub 20211220. doi: 10.1016/j.jpeds.2021.12.022. PubMed PMID: 34942183; PMCID: PMC8686454.
  13. Beinvogl B, Palmer N, Kohane I, Nurko S. Healthcare spending and utilization for pediatric Irritable Bowel Syndrome in a commercially insured population. Neurogastroenterol Motil. 2021;33(11):e14147. Epub 20210405. doi: 10.1111/nmo.14147. PubMed PMID: 33818857.
  14. Beinvogl BC, Manini ML, Camilleri M, Donato LJ, Harmsen WS, Absah I, Burch E, Schechter NL, Nurko S. Markers of Bile Acid Metabolism in Pediatric Diarrhea Predominant Irritable Bowel Syndrome and Healthy Controls. J Pediatr Gastroenterol Nutr. 2021;72(6):859-65. doi: 10.1097/MPG.0000000000003067. PubMed PMID: 33976086.
  15. Berinstein JA, El-Dalati S, Chey WD. Life-Threatening Gastrointestinal Bleeding in an Immunocompromised Patient. Gastroenterology. 2021;161(3):e6-e7. Epub 20210203. doi: 10.1053/j.gastro.2021.01.227. PubMed PMID: 33545144.
  16. Berry SK, Chey WD. Integrated Care for Irritable Bowel Syndrome: The Future Is Now. Gastroenterol Clin North Am. 2021;50(3):713-20. Epub 20210703. doi: 10.1016/j.gtc.2021.04.006. PubMed PMID: 34304796.
  17. Bohn L, Tornblom H, Van Oudenhove L, Simren M, Storsrud S. A randomized double-blind placebo-controlled crossover pilot study: Acute effects of the enzyme alpha-galactosidase on gastrointestinal symptoms in irritable bowel syndrome patients. Neurogastroenterol Motil. 2021;33(7):e14094. Epub 20210222. doi: 10.1111/nmo.14094. PubMed PMID: 33619835.
  18. Bonfiglio F, Liu X, Smillie C, Pandit A, Kurilshikov A, Bacigalupe R, Zheng T, Nim H, Garcia-Etxebarria K, Bujanda L, Andreasson A, Agreus L, Walter S, Abecasis G, Eijsbouts C, Jostins L, Parkes M, Hughes DA, Timpson N, Raes J, Franke A, Kennedy NA, Regev A, Zhernakova A, Simren M, Camilleri M, D’Amato M. GWAS of stool frequency provides insights into gastrointestinal motility and irritable bowel syndrome. Cell Genom. 2021;1(3):None. Epub 20211208. doi: 10.1016/j.xgen.2021.100069. PubMed PMID: 34957435; PMCID: PMC8654685.
  19. Bor S, Lehert P, Chalbaud A, Tack J. Efficacy of pinaverium bromide in the treatment of irritable bowel syndrome: a systematic review and meta-analysis. Therap Adv Gastroenterol. 2021;14:17562848211033740. Epub 20210915. doi: 10.1177/17562848211033740. PubMed PMID: 34539813; PMCID: PMC8447090.
  20. Bosman M, Elsenbruch S, Corsetti M, Tack J, Simren M, Winkens B, Boumans T, Masclee A, Keszthelyi D. The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(6):459-73. Epub 20210323. doi: 10.1016/S2468-1253(21)00023-6. PubMed PMID: 33765447.
  21. Brenner DM, Lacy BE. Antispasmodics for Chronic Abdominal Pain: Analysis of North American Treatment Options. Am J Gastroenterol. 2021;116(8):1587-600. doi: 10.14309/ajg.0000000000001266. PubMed PMID: 33993133; PMCID: PMC8315189.
  22. Camilleri M, Hale M, Morlion B, Tack J, Webster L, Wild J. Naldemedine Improves Patient-Reported Outcomes of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain in the COMPOSE Phase 3 Studies. J Pain Res. 2021;14:2179-89. Epub 20210716. doi: 10.2147/JPR.S282738. PubMed PMID: 34295186; PMCID: PMC8291809.
  23. Camilleri M, Nurko S. Bile Acid Diarrhea in Adults and Adolescents. Neurogastroenterol Motil. 2021:e14287. Epub 20211109. doi: 10.1111/nmo.14287. PubMed PMID: 34751982.
  24. Cangemi DJ, Lacy BE. Gastroparesis. Curr Opin Gastroenterol. 2021;37(6):596-601. doi: 10.1097/MOG.0000000000000782. PubMed PMID: 34560721.
  25. Cangemi DJ, Lacy BE, Wise J. Diagnosing Small Intestinal Bacterial Overgrowth: A Comparison of Lactulose Breath Tests to Small Bowel Aspirates. Dig Dis Sci. 2021;66(6):2042-50. Epub 20200717. doi: 10.1007/s10620-020-06484-z. PubMed PMID: 32681227.
  26. Cash BD, Lacy BE, Watton C, Schoenfeld PS, Weissman D. Post-marketing reports of pancreatitis in eluxadoline-treated patients pre and post US label change. Therap Adv Gastroenterol. 2021;14:17562848211001725. Epub 20210410. doi: 10.1177/17562848211001725. PubMed PMID: 33953798; PMCID: PMC8042552.
  27. Chang L. How to Approach a Patient with Difficult-to-Treat IBS. Gastroenterology. 2021;161(4):1092-8 e3. Epub 20210728. doi: 10.1053/j.gastro.2021.07.034. PubMed PMID: 34331916.
  28. Chang L, Lacy BE, Moshiree B, Kassebaum A, Abel JL, Hanlon J, Bartolini W, Boinpally R, Bochenek W, Fox SM, Mallick M, Tripp K, Omniewski N, Shea E, Borgstein N. Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System. Am J Gastroenterol. 2021;116(9):1929-37. doi: 10.14309/ajg.0000000000001334. PubMed PMID: 34465695.
  29. Chen JJ, Kitzia Colliard RN, Nurko S, Rodriguez L. Melanosis Coli Is Not Associated with Colonic Dysmotility Nor Severity of Pediatric Functional Constipation. Dig Dis Sci. 2021. Epub 20210811. doi: 10.1007/s10620-021-07191-z. PubMed PMID: 34379221.
  30. Chey SW, Chey WD, Jackson K, Eswaran S. Exploratory Comparative Effectiveness Trial of Green Kiwifruit, Psyllium, or Prunes in US Patients With Chronic Constipation. Am J Gastroenterol. 2021;116(6):1304-12. doi: 10.14309/ajg.0000000000001149. PubMed PMID: 34074830.
  31. Chey WD. Irritable Bowel Syndrome. Gastroenterol Clin North Am. 2021;50(3):xv-xvi. doi: 10.1016/j.gtc.2021.04.007. PubMed PMID: 34304798.
  32. Chey WD, Baker JR, Watts L, Harris A, Shah ED. Development of a Simple, Point-of-Care Device to Test Anorectal Function in Patients with Constipation: Randomized Clinical Trial. Clin Gastroenterol Hepatol. 2021. Epub 20211202. doi: 10.1016/j.cgh.2021.11.034. PubMed PMID: 34864156.
  33. Chey WD, Keefer L, Whelan K, Gibson PR. Behavioral and Diet Therapies in Integrated Care for Patients With Irritable Bowel Syndrome. Gastroenterology. 2021;160(1):47-62. Epub 20201019. doi: 10.1053/j.gastro.2020.06.099. PubMed PMID: 33091411.
  34. Chey WD, Lembo AJ, Yang Y, Rosenbaum DP. Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 26-Week, Placebo-Controlled Phase 3 Trial (T3MPO-2). Am J Gastroenterol. 2021;116(6):1294-303. doi: 10.14309/ajg.0000000000001056. PubMed PMID: 33337659; PMCID: PMC8183489.
  35. Chey WD, Sayuk GS, Bartolini W, Reasner DS, Fox SM, Bochenek W, Boinpally R, Shea E, Tripp K, Borgstein N. Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation. Am J Gastroenterol. 2021;116(2):354-61. doi: 10.14309/ajg.0000000000000967. PubMed PMID: 33065589; PMCID: PMC8279899.
  36. Corsetti M, Brown S, Chiarioni G, Dimidi E, Dudding T, Emmanuel A, Fox M, Ford AC, Giordano P, Grossi U, Henderson M, Knowles CH, O’Connell PR, Quigley EMM, Simren M, Spiller R, Whelan K, Whitehead WE, Williams AB, Scott SM. Chronic constipation in adults: Contemporary perspectives and clinical challenges. 2: Conservative, behavioural, medical and surgical treatment. Neurogastroenterol Motil. 2021;33(7):e14070. Epub 20210201. doi: 10.1111/nmo.14070. PubMed PMID: 33522079.
  37. Dinning PG, Wiklendt L, Costa M, Brookes SJH, Amicangelo M, Whitter L, Nurko S. Duodenal and proximal jejunal motility inhibition associated with bisacodyl-induced colonic high-amplitude propagating contractions. Am J Physiol Gastrointest Liver Physiol. 2021;321(3):G325-G34. Epub 20210707. doi: 10.1152/ajpgi.00209.2021. PubMed PMID: 34231391.
  38. Drossman DA, Chang L, Deutsch JK, Ford AC, Halpert A, Kroenke K, Nurko S, Ruddy J, Snyder J, Sperber A. A Review of the Evidence and Recommendations on Communication Skills and the Patient-Provider Relationship: A Rome Foundation Working Team Report. Gastroenterology. 2021;161(5):1670-88 e7. Epub 20210728. doi: 10.1053/j.gastro.2021.07.037. PubMed PMID: 34331912.
  39. Dubinsky MC, Dotan I, Rubin DT, Bernauer M, Patel D, Cheung R, Modesto I, Latymer M, Keefer L. Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review. Expert Rev Gastroenterol Hepatol. 2021;15(9):985-97. Epub 20210615. doi: 10.1080/17474124.2021.1911644. PubMed PMID: 34130572.
  40. Feingold JH, Drossman DA. Deconstructing stigma as a barrier to treating DGBI: Lessons for clinicians. Neurogastroenterol Motil. 2021;33(2):e14080. Epub 20210123. doi: 10.1111/nmo.14080. PubMed PMID: 33484225; PMCID: PMC8091160.
  41. Feingold JH, Drossman DA, Chey W, Kurlander JE, Morris CB, Bangdiwala S, Keefer L. Preliminary development and validation of the Patient-Physician Relationship Scale for physicians for disorders of gut-brain interaction. Neurogastroenterol Motil. 2021;33(2):e13976. Epub 20200901. doi: 10.1111/nmo.13976. PubMed PMID: 32875659; PMCID: PMC8065374.
  42. Feingold JH, Kaye-Kauderer H, Mendiolaza M, Dubinsky MC, Keefer L, Gorbenko K. Empowered transitions: Understanding the experience of transitioning from pediatric to adult care among adolescents with inflammatory bowel disease and their parents using photovoice. J Psychosom Res. 2021;143:110400. Epub 20210217. doi: 10.1016/j.jpsychores.2021.110400. PubMed PMID: 33631616; PMCID: PMC8098753.
  43. Fortea M, Jain P, Demedts I, Tack J, Vanuytsel T, Cirillo C, Vanden Berghe P. Live Imaging of Primary Neurons in Long-Term Cryopreserved Human Nerve Tissue. eNeuro. 2021;8(6). Epub 20211201. doi: 10.1523/ENEURO.0388-21.2021. PubMed PMID: 34759050; PMCID: PMC8638677.
  44. Gholamrezaei A, Van Diest I, Aziz Q, Pauwels A, Tack J, Vlaeyen JWS, Van Oudenhove L. Effect of slow, deep breathing on visceral pain perception and its underlying psychophysiological mechanisms. Neurogastroenterol Motil. 2021:e14242. Epub 20210811. doi: 10.1111/nmo.14242. PubMed PMID: 34378834.
  45. Ghoz H, Stancampiano FF, Valery JR, Nordelo K, Malviya B, Lacy BE, Francis D, DeVault K, Bouras E, Krishna M, Palmer WC. Extent of eosinophilic esophagitis predicts response to treatment. Endosc Int Open. 2021;9(8):E1234-E42. Epub 20210716. doi: 10.1055/a-1492-2650. PubMed PMID: 34447870; PMCID: PMC8383079.
  46. Grinsvall C, Van Oudenhove L, Dupont P, Ryu HJ, Ljungberg M, Labus JS, Tornblom H, Mayer EA, Simren M. Altered Structural Covariance of Insula, Cerebellum and Prefrontal Cortex Is Associated with Somatic Symptom Levels in Irritable Bowel Syndrome (IBS). Brain Sci. 2021;11(12). Epub 20211129. doi: 10.3390/brainsci11121580. PubMed PMID: 34942882; PMCID: PMC8699158.
  47. Guadagnoli L, Yadlapati R, Taft T, Pandolfino JE, Tye M, Keefer L. Esophageal hypervigilance is prevalent across gastroesophageal reflux disease presentations. Neurogastroenterol Motil. 2021;33(8):e14081. Epub 20210111. doi: 10.1111/nmo.14081. PubMed PMID: 33432708; PMCID: PMC8272741.
  48. Gyawali CP, Baker JR, Moshiree B, Rao S, Neshatian L, Nguyen L, Chey WD, Saad R, Garza JM, Waseem S, Khan AR, Pandolfino JE. Response to Richter and Vaezi. Am J Gastroenterol. 2021;116(1):214-5. doi: 10.14309/ajg.0000000000001021. PubMed PMID: 33136562.
  49. Hale ME, Wild JE, Yamada T, Yokota T, Tack J, Andresen V, Drewes AM. Naldemedine is effective in the treatment of opioid-induced constipation in patients with chronic non-cancer pain who had a poor response to laxatives. Therap Adv Gastroenterol. 2021;14:17562848211032320. Epub 20210731. doi: 10.1177/17562848211032320. PubMed PMID: 34377150; PMCID: PMC8326612.
  50. Hirten RP, Danieletto M, Scheel R, Shervey M, Ji J, Hu L, Sauk J, Chang L, Arnrich B, Bttinger E, Dudley J, Keefer L, Sands BE. Longitudinal Autonomic Nervous System Measures Correlate With Stress and Ulcerative Colitis Disease Activity and Predict Flare. Inflamm Bowel Dis. 2021;27(10):1576-84. doi: 10.1093/ibd/izaa323. PubMed PMID: 33382065.
  51. Hirten RP, Danieletto M, Tomalin L, Choi KH, Zweig M, Golden E, Kaur S, Helmus D, Biello A, Pyzik R, Calcagno C, Freeman R, Sands BE, Charney D, Bottinger EP, Murrough JW, Keefer L, Suarez-Farinas M, Nadkarni GN, Fayad ZA. Factors Associated With Longitudinal Psychological and Physiological Stress in Health Care Workers During the COVID-19 Pandemic: Observational Study Using Apple Watch Data. J Med Internet Res. 2021;23(9):e31295. Epub 20210913. doi: 10.2196/31295. PubMed PMID: 34379602; PMCID: PMC8439178.
  52. Hirten RP, Danieletto M, Tomalin L, Choi KH, Zweig M, Golden E, Kaur S, Helmus D, Biello A, Pyzik R, Charney A, Miotto R, Glicksberg BS, Levin M, Nabeel I, Aberg J, Reich D, Charney D, Bottinger EP, Keefer L, Suarez-Farinas M, Nadkarni GN, Fayad ZA. Use of Physiological Data From a Wearable Device to Identify SARS-CoV-2 Infection and Symptoms and Predict COVID-19 Diagnosis: Observational Study. J Med Internet Res. 2021;23(2):e26107. Epub 20210222. doi: 10.2196/26107. PubMed PMID: 33529156; PMCID: PMC7901594.
  53. Hirten RP, Stanley S, Danieletto M, Borman Z, Grinspan A, Rao P, Sauk J, Chang L, Arnrich B, Bttinger E, Keefer L, Sands BE. Wearable Devices Are Well Accepted by Patients in the Study and Management of Inflammatory Bowel Disease: A Survey Study. Dig Dis Sci. 2021;66(6):1836-44. Epub 20200723. doi: 10.1007/s10620-020-06493-y. PubMed PMID: 32705439.
  54. Howden CW, Sheldon KL, Almenoff JS, Chey WD. Pitfalls of Physician-Directed Treatment of Helicobacter pylori: Results from Two Phase 3 Clinical Trials and Real-World Prescribing Data. Dig Dis Sci. 2021. Epub 20211204. doi: 10.1007/s10620-021-07323-5. PubMed PMID: 34862940.
  55. Iribarren C, Magnusson MK, Vigsnaes LK, Aziz I, Amundsen ID, Suligoj T, Juge N, Patel P, Sapnara M, Johnsen L, Sorensen N, Sundin J, Tornblom H, Simren M, Ohman L. The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome. Nutrients. 2021;13(11). Epub 20211027. doi: 10.3390/nu13113836. PubMed PMID: 34836092; PMCID: PMC8622683.
  56. Jagielski CH, Chey WD, Riehl ME. Influence of trauma on clinical outcomes, quality of life and healthcare resource utilization following psychogastroenterology intervention. J Psychosom Res. 2021;146:110481. Epub 20210331. doi: 10.1016/j.jpsychores.2021.110481. PubMed PMID: 33867174.
  57. Kamp KJ, Han C, Shulman RJ, Cain KC, Barney P, Opp MR, Chang L, Burr RL, Heitkemper MM. Cytokine Levels and Symptoms Among Women with Irritable Bowel Syndrome: Considering the Role of Hormonal Contraceptive Use. Biol Res Nurs. 2021;23(2):171-9. Epub 20200717. doi: 10.1177/1099800420941252. PubMed PMID: 32677464; PMCID: PMC8264855.
  58. Keefer L. What can we do to tackle anxiety and depression in patients with inflammatory bowel disease? Lancet Gastroenterol Hepatol. 2021;6(5):337-8. Epub 20210312. doi: 10.1016/S2468-1253(21)00066-2. PubMed PMID: 33721556.
  59. Keefer L, Gorbenko K, Siganporia T, Manning L, Tse S, Biello A, Ungaro R, Cohen LJ, Cohen BL, Dubinsky MC. Resilience-based Integrated IBD Care Is Associated With Reductions in Health Care Use and Opioids. Clin Gastroenterol Hepatol. 2021. Epub 20211116. doi: 10.1016/j.cgh.2021.11.013. PubMed PMID: 34798332.
  60. Keefer L, Ko CW, Ford AC. AGA Clinical Practice Update on Management of Chronic Gastrointestinal Pain in Disorders of Gut-Brain Interaction: Expert Review. Clin Gastroenterol Hepatol. 2021;19(12):2481-8 e1. Epub 20210703. doi: 10.1016/j.cgh.2021.07.006. PubMed PMID: 34229040.
  61. Khlevner J, Rosen R, Ambartsumyan L, Lusman SS, Rosen JM, Yacob D, Mousa H, Nurko S, Di Lorenzo C, Boruta M, Ratcliffe EM, Feinstein L, Snyder J, Wood RJ, Graham K, Saps M, Gyawali CP, Rodriguez L, Belkind-Gerson J. Development of Entrustable Professional Activities and Standards in Training in Pediatric Neurogastroenterology and Motility: North American Society for Pediatric Gastroenterology, Hepatology and Nutrition and American Neurogastroenterology and Motility Society Position Paper. J Pediatr Gastroenterol Nutr. 2021;72(1):168-80. doi: 10.1097/MPG.0000000000002965. PubMed PMID: 33075010.
  62. Klaassen T, Smeets FGM, Vork L, Tack J, Talley NJ, Simren M, Aziz Q, Ford AC, Kruimel JW, Conchillo JM, Leue C, Masclee AAM, Keszthelyi D. Psychometric evaluation of an experience sampling method-based patient-reported outcome measure in functional dyspepsia. Neurogastroenterol Motil. 2021;33(9):e14136. Epub 20210502. doi: 10.1111/nmo.14136. PubMed PMID: 33934444; PMCID: PMC8519073.
  63. Lacy BE, Brenner DM, Chey WD. Re-evaluation of the Cardiovascular Safety Profile of Tegaserod: A Review of the Clinical Data. Clin Gastroenterol Hepatol. 2021. Epub 20210525. doi: 10.1016/j.cgh.2021.05.040. PubMed PMID: 34048937.
  64. Lacy BE, Cangemi D. Pyloric dilation with EsoFLIP: Time to “flip” treatment options for refractory gastroparesis? Gastrointest Endosc. 2021;94(3):495-7. Epub 20210701. doi: 10.1016/j.gie.2021.04.014. PubMed PMID: 34218923.
  65. Lacy BE, Cangemi D. Gastric POEM for gastroparesis: Panacea, placebo, or pathway to the future? Gastrointest Endosc. 2021;94(1):45-7. Epub 20210311. doi: 10.1016/j.gie.2021.01.004. PubMed PMID: 33715877.
  66. Lacy BE, Cangemi D, Vazquez-Roque M. Management of Chronic Abdominal Distension and Bloating. Clin Gastroenterol Hepatol. 2021;19(2):219-31 e1. Epub 20200401. doi: 10.1016/j.cgh.2020.03.056. PubMed PMID: 32246999.
  67. Lacy BE, Cangemi DJ. Controversies in Gastroparesis: Discussing the Sticky Points. Am J Gastroenterol. 2021;116(8):1572-6. doi: 10.14309/ajg.0000000000001243. PubMed PMID: 33767098.
  68. Lacy BE, Crowell MD, Cangemi DJ, Lunsford TN, Simren M, Tack J. Diagnostic Evaluation of Gastric Motor and Sensory Disorders. Am J Gastroenterol. 2021;116(12):2345-56. doi: 10.14309/ajg.0000000000001562. PubMed PMID: 35134012.
  69. Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, Moshiree B. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2021;116(1):17-44. doi: 10.14309/ajg.0000000000001036. PubMed PMID: 33315591.
  70. Lacy BE, Shea EP, Manuel M, Abel JL, Jiang H, Taylor DCA. Lessons learned: Chronic idiopathic constipation patient experiences with over-the-counter medications. PLoS One. 2021;16(1):e0243318. Epub 20210111. doi: 10.1371/journal.pone.0243318. PubMed PMID: 33428631; PMCID: PMC7799845.
  71. Lacy BE, Spiegel B. The “Changing Landscapes” Special Edition. Am J Gastroenterol. 2021;116(10):1969. doi: 10.14309/ajg.0000000000001512. PubMed PMID: 34618694.
  72. Lam CY, Palsson OS, Whitehead WE, Sperber AD, Tornblom H, Simren M, Aziz I. Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome. Clin Gastroenterol Hepatol. 2021;19(2):277-87 e3. Epub 20200225. doi: 10.1016/j.cgh.2020.02.034. PubMed PMID: 32109633.
  73. LeBrett WG, Chen FW, Yang L, Chang L. Increasing Rates of Opioid Prescriptions for Gastrointestinal Diseases in the United States. Am J Gastroenterol. 2021;116(4):796-807. doi: 10.14309/ajg.0000000000001052. PubMed PMID: 33982950.
  74. LeBrett WG, Iyengar PS, Lee AH, Chen FW, Chang L. High Opioid Prescribing Profiles Among Gastroenterologists: A Nationwide Analysis. Clin Gastroenterol Hepatol. 2021. Epub 20211016. doi: 10.1016/j.cgh.2021.10.014. PubMed PMID: 34666155.
  75. Lenhart A, Chen F, Condon A, Kardashian A, El-Nachef N, Ucla Gi Division B, Chang L. Gender and Other Factors Associated with Endoscopy Volume Among U.S. Gastroenterology Fellows. Clin Gastroenterol Hepatol. 2021. Epub 20211007. doi: 10.1016/j.cgh.2021.10.004. PubMed PMID: 34628079.
  76. Luo Y, Keefer L. Role of psychological questionnaires in clinical practice and research within functional gastrointestinal disorders. Neurogastroenterol Motil. 2021;33(12):e14297. Epub 20211117. doi: 10.1111/nmo.14297. PubMed PMID: 34786802.
  77. Mahurkar-Joshi S, Rankin CR, Videlock EJ, Soroosh A, Verma A, Khandadash A, Iliopoulos D, Pothoulakis C, Mayer EA, Chang L. The Colonic Mucosal MicroRNAs, MicroRNA-219a-5p, and MicroRNA-338-3p Are Downregulated in Irritable Bowel Syndrome and Are Associated With Barrier Function and MAPK Signaling. Gastroenterology. 2021;160(7):2409-22 e19. Epub 20210220. doi: 10.1053/j.gastro.2021.02.040. PubMed PMID: 33617890; PMCID: PMC8169529.
  78. Marasco G, Maida M, Morreale GC, Licata M, Renzulli M, Cremon C, Stanghellini V, Barbara G. Gastrointestinal Bleeding in COVID-19 Patients: A Systematic Review with Meta-Analysis. Can J Gastroenterol Hepatol. 2021;2021:2534975. Epub 20210901. doi: 10.1155/2021/2534975. PubMed PMID: 34513750; PMCID: PMC8429023.
  79. Mauloni PA, Capuani F, Paone C, Marasco G, Bellacosa L, Cogliandro RF, Cremon C, Barbara G, Vasuri F, Stanghellini V. An unusual cause of diarrhoea: case report and literature review of olmesartan-associated enteropathy. Eur J Gastroenterol Hepatol. 2021;33(1S Suppl 1):e1060-e6. doi: 10.1097/MEG.0000000000002208. PubMed PMID: 34334714.
  80. Melchior C, Algera J, Colomier E, Tornblom H, Simren M, Storsrud S. Food Avoidance and Restriction in Irritable Bowel Syndrome: Relevance for Symptoms, Quality of Life and Nutrient Intake. Clin Gastroenterol Hepatol. 2021. Epub 20210703. doi: 10.1016/j.cgh.2021.07.004. PubMed PMID: 34229035.
  81. Midenfjord I, Borg A, Tornblom H, Simren M. Cumulative Effect of Psychological Alterations on Gastrointestinal Symptom Severity in Irritable Bowel Syndrome. Am J Gastroenterol. 2021;116(4):769-79. doi: 10.14309/ajg.0000000000001038. PubMed PMID: 33982947.
  82. Midenfjord I, Grinsvall C, Koj P, Carnerup I, Tornblom H, Simren M. Central sensitization and severity of gastrointestinal symptoms in irritable bowel syndrome, chronic pain syndromes, and inflammatory bowel disease. Neurogastroenterol Motil. 2021;33(12):e14156. Epub 20210416. doi: 10.1111/nmo.14156. PubMed PMID: 33860970.
  83. Mohr S, Fritz N, Hammer C, Martinez C, Berens S, Schmitteckert S, Wahl V, Schmidt M, Houghton LA, Goebel-Stengel M, Kabisch M, Gotze D, Milovac I, D’Amato M, Zheng T, Roth R, Monnikes H, Engel F, Gauss A, Tesarz J, Raithel M, Andresen V, Frieling T, Keller J, Pehl C, Stein-Thoringer C, Clarke G, Kennedy PJ, Cryan JF, Dinan TG, Quigley EMM, Spiller R, Beltran C, Madrid AM, Torres V, Perez de Arce E, Herzog W, Mayer EA, Sayuk G, Gazouli M, Karamanolis G, Kapur-Pojskic L, Bustamante M, Rabionet R, Estivil X, Franke A, Lieb W, Boeckxstaens G, Wouters MM, Simren M, Rappold GA, Vicario M, Santos J, Schaefert R, Lorenzo-Bermejo J, Niesler B. The alternative serotonin transporter promoter P2 impacts gene function in females with irritable bowel syndrome. J Cell Mol Med. 2021;25(16):8047-61. Epub 20210624. doi: 10.1111/jcmm.16736. PubMed PMID: 34165249; PMCID: PMC8358858.
  84. Moktan VP, Robelin K, Lacy BE. 70-Year-Old Man With Chronic Nausea and Vomiting. Mayo Clin Proc. 2021;96(12):3142-6. Epub 20211030. doi: 10.1016/j.mayocp.2021.03.043. PubMed PMID: 34728059.
  85. Morera C, Nurko S, Rodriguez L. Evaluation of Fecal Incontinence in Pediatric Functional Constipation: Clinical Utility of Anorectal and Colon Manometry. J Pediatr Gastroenterol Nutr. 2021;72(3):361-5. doi: 10.1097/MPG.0000000000002978. PubMed PMID: 33560756.
  86. Navas CM, Wadas ED, Zbib NH, Crowell MD, Lacy BE. Gastroparesis and Severity of Delayed Gastric Emptying: Comparison of Patient Characteristics, Treatments and Medication Adverse Events. Dig Dis Sci. 2021;66(2):526-34. Epub 20200418. doi: 10.1007/s10620-020-06258-7. PubMed PMID: 32306190.
  87. Nelson AD, Black CJ, Houghton LA, Lugo-Fagundo NS, Lacy BE, Ford AC. Systematic review and network meta-analysis: efficacy of licensed drugs for abdominal bloating in irritable bowel syndrome with constipation. Aliment Pharmacol Ther. 2021;54(2):98-108. Epub 20210611. doi: 10.1111/apt.16437. PubMed PMID: 34114657.
  88. Ng TSC, Putta N, Kwatra NS, Drubach LA, Rosen R, Fahey FH, Flores A, Nurko S, Voss SD. Response to Febo-Rodriguez et al. Am J Gastroenterol. 2021;116(7):1553. doi: 10.14309/ajg.0000000000001214. PubMed PMID: 34183582.
  89. Nowlin S, Manning L, Keefer L, Gorbenko K. Perceptive eating as part of the journey in inflammatory bowel disease: Lessons learned from lived experience. Clin Nutr ESPEN. 2021;41:299-304. Epub 20210107. doi: 10.1016/j.clnesp.2020.11.017. PubMed PMID: 33487280.
  90. Nulsen B, LeBrett W, Drossman DA, Chang L. A survey of gastroenterologists in the United States on the use of central neuromodulators for treating irritable bowel syndrome. Aliment Pharmacol Ther. 2021;54(3):281-91. Epub 20210620. doi: 10.1111/apt.16467. PubMed PMID: 34148256.
  91. Nybacka S, Simren M, Storsrud S, Tornblom H, Winkvist A, Lindqvist HM. Changes in serum and urinary metabolomic profile after a dietary intervention in patients with irritable bowel syndrome. PLoS One. 2021;16(10):e0257331. Epub 20211011. doi: 10.1371/journal.pone.0257331. PubMed PMID: 34634050; PMCID: PMC8504738.
  92. Ohman L, Lasson A, Strombeck A, Isaksson S, Hesselmar M, Simren M, Strid H, Magnusson MK. Fecal microbiota dynamics during disease activity and remission in newly diagnosed and established ulcerative colitis. Sci Rep. 2021;11(1):8641. Epub 20210421. doi: 10.1038/s41598-021-87973-7. PubMed PMID: 33883600; PMCID: PMC8060394.
  93. Onken J, Chang L, Kanwal F. Unconscious Bias in Peer Review. Clin Gastroenterol Hepatol. 2021;19(3):419-20. Epub 20201203. doi: 10.1016/j.cgh.2020.12.001. PubMed PMID: 33279782.
  94. Ortengren AR, Ramkissoon RA, Chey WD, Baker JR, Staller K, Iturrino J, Shah ED. Anorectal manometry to diagnose dyssynergic defecation: Systematic review and meta-analysis of diagnostic test accuracy. Neurogastroenterol Motil. 2021;33(11):e14137. Epub 20210327. doi: 10.1111/nmo.14137. PubMed PMID: 33772969.
  95. Parker CH, Naliboff BD, Shih W, Presson AP, Kilpatrick L, Gupta A, Liu C, Keefer LA, Sauk JS, Hirten R, Sands BE, Chang L. The Role of Resilience in Irritable Bowel Syndrome, Other Chronic Gastrointestinal Conditions, and the General Population. Clin Gastroenterol Hepatol. 2021;19(12):2541-50 e1. Epub 20200821. doi: 10.1016/j.cgh.2020.08.043. PubMed PMID: 32835842; PMCID: PMC7897330.
  96. Parker S, Palsson O, Sanders DS, Simren M, Sperber AD, Tornblom H, Urwin H, Whitehead W, Aziz I. Functional Gastrointestinal Disorders and Associated Health Impairment in Individuals with Celiac Disease. Clin Gastroenterol Hepatol. 2021. Epub 20210721. doi: 10.1016/j.cgh.2021.07.026. PubMed PMID: 34298190.
  97. Person H, Keefer L. Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis. Prog Neuropsychopharmacol Biol Psychiatry. 2021;107:110209. Epub 20201214. doi: 10.1016/j.pnpbp.2020.110209. PubMed PMID: 33326819; PMCID: PMC8382262.
  98. Philippou A, Sehgal P, Ungaro RC, Wang K, Bagiella E, Dubinsky MC, Keefer L. High Levels of Psychological Resilience Are Associated With Decreased Anxiety in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2021. Epub 20210827. doi: 10.1093/ibd/izab200. PubMed PMID: 34448855.
  99. Polster A, Ohman L, Tap J, Derrien M, Le Neve B, Sundin J, Tornblom H, Cvijovic M, Simren M. A novel stepwise integrative analysis pipeline reveals distinct microbiota-host interactions and link to symptoms in irritable bowel syndrome. Sci Rep. 2021;11(1):5521. Epub 20210309. doi: 10.1038/s41598-021-84686-9. PubMed PMID: 33750831; PMCID: PMC7943560.
  100. Pourmand K, Schiano TD, Motwani Y, Kriss M, Keefer L, Patel A. Burnout Among Transplant Hepatologists in the United States. Liver Transpl. 2021. Epub 20211126. doi: 10.1002/lt.26375. PubMed PMID: 34826182.
  101. Queneherve L, Drui D, Blin J, Pere M, Coron E, Barbara G, Barbaro MR, Cariou B, Neunlist M, Masson D, Bach-Ngohou K. Digestive symptoms in daily life of chronic adrenal insufficiency patients are similar to irritable bowel syndrome symptoms. Sci Rep. 2021;11(1):8077. Epub 20210413. doi: 10.1038/s41598-021-87158-2. PubMed PMID: 33850177; PMCID: PMC8044180.
  102. Rangel Paniz G, Lebow J, Sim L, Lacy BE, Farraye FA, Werlang ME. Eating Disorders: Diagnosis and Management Considerations for the IBD Practice. Inflamm Bowel Dis. 2021. Epub 20210607. doi: 10.1093/ibd/izab138. PubMed PMID: 34096582.
  103. Reicher-Atir R, Avnat-Becker L, Levy S, Sperber AD, Dickman R. Psychological defense mechanisms and use of corporeal discourse: a comparison between patients with irritable bowel syndrome, medical personnel and healthy volunteers. Eur J Gastroenterol Hepatol. 2021;33(4):514-21. doi: 10.1097/MEG.0000000000001940. PubMed PMID: 32956177.
  104. Rej A, Shaw CC, Buckle RL, Trott N, Agrawal A, Mosey K, Sanders K, Allen R, Martin S, Newton A, Robinson K, Elphick D, Chey WD, Aziz I, Sanders DS. The low FODMAP diet for IBS; A multicentre UK study assessing long term follow up. Dig Liver Dis. 2021;53(11):1404-11. Epub 20210601. doi: 10.1016/j.dld.2021.05.004. PubMed PMID: 34083153.
  105. Rodriguez L, Heinz N, Colliard K, Amicangelo M, Nurko S. Diagnostic and clinical utility of the wireless motility capsule in children: A study in patients with functional gastrointestinal disorders. Neurogastroenterol Motil. 2021;33(4):e14032. Epub 20201112. doi: 10.1111/nmo.14032. PubMed PMID: 33184926.
  106. Ruggiero M, Somigliana E, Tassis B, Li Piani L, Uceda Renteria S, Barbara G, Lunghi G, Pietrasanta C, Ferrazzi E. Clinical relevance of SARS-CoV-2 infection in late pregnancy. BMC Pregnancy Childbirth. 2021;21(1):505. Epub 20210712. doi: 10.1186/s12884-021-03985-1. PubMed PMID: 34253173; PMCID: PMC8273567.
  107. Saps M, Nurko S, Benninga MA, Di Lorenzo C, Garza JM, Thapar N, Richards K, Lee JJ, Altepeter T. A Collaborative Effort to Advance Drug Development in Pediatric Constipation and Irritable Bowel Syndrome. J Pediatr Gastroenterol Nutr. 2021;73(2):145-9. doi: 10.1097/MPG.0000000000003191. PubMed PMID: 34091541.
  108. Scarpellini E, Ianiro G, Tack J. Editorial: Pharmacological Treatments Affecting Gastro-Intestinal Motility in Man. Front Pharmacol. 2021;12:801136. Epub 20220119. doi: 10.3389/fphar.2021.801136. PubMed PMID: 35126136; PMCID: PMC8807642.
  109. Schechter NL, Coakley R, Nurko S. The Golden Half Hour in Chronic Pediatric Pain-Feedback as the First Intervention. JAMA Pediatr. 2021;175(1):7-8. doi: 10.1001/jamapediatrics.2020.1798. PubMed PMID: 32628256.
  110. Schmulson M. Probiotics: To Use or Not to Use? That Is the Question. Am J Gastroenterol. 2021;116(7):1396-7. doi: 10.14309/ajg.0000000000001299. PubMed PMID: 33973898.
  111. Schmulson M, Davalos De la Rosa MF, Linares-Garcia L, Morales-Guzman AS, Balbuena R, Lau C. The human translation of the postinfectious irritable bowel syndrome like rat model with antivinculin production after immunization with cytolethal distending toxin B. Neurogastroenterol Motil. 2021;33(1):e14042. Epub 20201124. doi: 10.1111/nmo.14042. PubMed PMID: 33232542.
  112. Schmulson M, Gudino-Zayas M, Hani A, Sociedad Latinoamericana de N. The Impact of COVID-19 Pandemic on Neurogastroenterologists in Latin America: Results of an Online Survey. J Clin Gastroenterol. 2021;55(8):684-90. doi: 10.1097/MCG.0000000000001413. PubMed PMID: 33471492; PMCID: PMC8356844.
  113. Schol J, Wauters L, Dickman R, Drug V, Mulak A, Serra J, Enck P, Tack J, group Egc. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis. United European Gastroenterol J. 2021;9(7):883-4. Epub 20210714. doi: 10.1002/ueg2.12090. PubMed PMID: 35099124.
  114. Schold JD, Augustine JJ, Huml AM, Fatica R, Nurko S, Wee A, Poggio ED. Effects of body mass index on kidney transplant outcomes are significantly modified by patient characteristics. Am J Transplant. 2021;21(2):751-65. Epub 20200827. doi: 10.1111/ajt.16196. PubMed PMID: 32654372; PMCID: PMC8905683.
  115. Sehgal P, Ungaro RC, Foltz C, Iacoviello B, Dubinsky MC, Keefer L. High Levels of Psychological Resilience Associated With Less Disease Activity, Better Quality of Life, and Fewer Surgeries in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2021;27(6):791-6. doi: 10.1093/ibd/izaa196. PubMed PMID: 32696966; PMCID: PMC8128407.
  116. Shah ED, Chang L, Lembo A, Staller K, Curley MA, Chey WD. Price Is Right: Exploring Prescription Drug Coverage Barriers for Irritable Bowel Syndrome Using Threshold Pricing Analysis. Dig Dis Sci. 2021;66(12):4140-8. Epub 20210112. doi: 10.1007/s10620-020-06806-1. PubMed PMID: 33433804.
  117. Shah ED, Chang L, Salwen-Deremer JK, Gibson PR, Keefer L, Muir JG, Eswaran S, Chey WD. Contrasting Clinician and Insurer Perspectives to Managing Irritable Bowel Syndrome: Multilevel Modeling Analysis. Am J Gastroenterol. 2021;116(4):748-57. doi: 10.14309/ajg.0000000000000989. PubMed PMID: 33982945.
  118. Shah ED, Lacy BE, Chey WD, Chang L, Brenner DM. Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials. Am J Gastroenterol. 2021;116(8):1601-11. doi: 10.14309/ajg.0000000000001313. PubMed PMID: 34047303; PMCID: PMC8315186.
  119. Shah ED, Salwen-Deremer JK, Gibson PR, Muir JG, Eswaran S, Chey WD. Pharmacologic, Dietary, and Psychological Treatments for Irritable Bowel Syndrome With Constipation: Cost Utility Analysis. MDM Policy Pract. 2021;6(1):2381468320978417. Epub 20210118. doi: 10.1177/2381468320978417. PubMed PMID: 33521290; PMCID: PMC7818007.
  120. Shah ED, Staller K, Nee J, Ahuja NK, Chan WW, Lembo A, Brenner DM, Siegel CA, Chey WD. Evaluating the Impact of Cost on the Treatment Algorithm for Chronic Idiopathic Constipation: Cost-Effectiveness Analysis. Am J Gastroenterol. 2021;116(10):2118-27. doi: 10.14309/ajg.0000000000001403. PubMed PMID: 34388141.
  121. Shah SL, Janisch NH, Crowell M, Lacy BE. Patients With Irritable Bowel Syndrome Are Willing to Take Substantial Medication Risks for Symptom Relief. Clin Gastroenterol Hepatol. 2021;19(1):80-6. Epub 20200411. doi: 10.1016/j.cgh.2020.04.003. PubMed PMID: 32289536.
  122. Sjolund J, Kull I, Bergstrom A, Jaras J, Ludvigsson JF, Tornblom H, Simren M, Olen O. Allergy-related diseases in childhood and risk for abdominal pain-related functional gastrointestinal disorders at 16 years-a birth cohort study. BMC Med. 2021;19(1):214. Epub 20210916. doi: 10.1186/s12916-021-02069-3. PubMed PMID: 34526042; PMCID: PMC8444367.
  123. Soifer L, Tawil J, Remes-Troche JM, Valdovinos MA, Schmulson M, grupo de colaboracion de EdlSLdN. Degree of concordance on the management of patients with gastroesophageal reflux disease. A study among specialists that are members of the Sociedad Latinoamericana de Neurogastroenterologia (SLNG). Rev Gastroenterol Mex (Engl Ed). 2021. Epub 20210719. doi: 10.1016/j.rgmx.2021.02.006. PubMed PMID: 34294483.
  124. Soifer L, Tawil J, Remes-Troche JM, Valdovinos MA, Schmulson M, Neurogastroenterologia GCGotSLd. Degree of concordance on the management of patients with gastroesophageal reflux disease. A study among specialists that are members of the Sociedad Latinoamericana de Neurogastroenterologia (SLNG). Rev Gastroenterol Mex (Engl Ed). 2021. Epub 20211116. doi: 10.1016/j.rgmxen.2021.11.004. PubMed PMID: 34794927.
  125. Sperber AD. Review article: epidemiology of IBS and other bowel disorders of gut-brain interaction (DGBI). Aliment Pharmacol Ther. 2021;54 Suppl 1:S1-S11. doi: 10.1111/apt.16582. PubMed PMID: 34927754.
  126. Sperber AD. Epidemiology and Burden of Irritable Bowel Syndrome: An International Perspective. Gastroenterol Clin North Am. 2021;50(3):489-503. doi: 10.1016/j.gtc.2021.04.001. PubMed PMID: 34304784.
  127. Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, Whitehead WE, Dumitrascu DL, Fang X, Fukudo S, Kellow J, Okeke E, Quigley EMM, Schmulson M, Whorwell P, Archampong T, Adibi P, Andresen V, Benninga MA, Bonaz B, Bor S, Fernandez LB, Choi SC, Corazziari ES, Francisconi C, Hani A, Lazebnik L, Lee YY, Mulak A, Rahman MM, Santos J, Setshedi M, Syam AF, Vanner S, Wong RK, Lopez-Colombo A, Costa V, Dickman R, Kanazawa M, Keshteli AH, Khatun R, Maleki I, Poitras P, Pratap N, Stefanyuk O, Thomson S, Zeevenhooven J, Palsson OS. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2021;160(1):99-114 e3. Epub 20200412. doi: 10.1053/j.gastro.2020.04.014. PubMed PMID: 32294476.
  128. Sperber AD, Freud T, Aziz I, Palsson OS, Drossman DA, Dumitrascu DL, Fang X, Fukudo S, Ghoshal UC, Kellow J, Khatun R, Okeke E, Quigley EMM, Schmulson M, Simren M, Tack J, Whitehead WE, Whorwell P, Bangdiwala SI. Greater Overlap of Rome IV Disorders of Gut-Brain Interactions Leads to Increased Disease Severity and Poorer Quality of Life. Clin Gastroenterol Hepatol. 2021. Epub 20210527. doi: 10.1016/j.cgh.2021.05.042. PubMed PMID: 34052391.
  129. Spiegel B, Lacy BE. Reflections on Our Editorship of The American Journal of Gastroenterology. Am J Gastroenterol. 2021;116(12):2313-5. doi: 10.14309/ajg.0000000000001558. PubMed PMID: 35134007.
  130. Strisciuglio C, Martinelli M, Lu P, Bar Lev MR, Beinvogl B, Benninga MA, Di Lorenzo C, Fiori Nastro F, Nurko S, Pearlstein H, Rosen R, Shamir R, Staiano A. Overall Impact of Coronavirus Disease 2019 Outbreak in Children With Functional Abdominal Pain Disorders: Results From the First Pandemic Phase. J Pediatr Gastroenterol Nutr. 2021;73(6):689-94. doi: 10.1097/MPG.0000000000003286. PubMed PMID: 34417400.
  131. Tack J, Verbeure W, Mori H, Schol J, Van den Houte K, Huang IH, Balsiger L, Broeders B, Colomier E, Scarpellini E, Carbone F. The gastrointestinal tract in hunger and satiety signalling. United European Gastroenterol J. 2021;9(6):727-34. Epub 20210621. doi: 10.1002/ueg2.12097. PubMed PMID: 34153172; PMCID: PMC8280794.
  132. Tap J, Storsrud S, Le Neve B, Cotillard A, Pons N, Dore J, Ohman L, Tornblom H, Derrien M, Simren M. Diet and gut microbiome interactions of relevance for symptoms in irritable bowel syndrome. Microbiome. 2021;9(1):74. Epub 20210326. doi: 10.1186/s40168-021-01018-9. PubMed PMID: 33771219; PMCID: PMC8004395.
  133. Tornblom H, Drossman DA. Psychopharmacologic Therapies for Irritable Bowel Syndrome. Gastroenterol Clin North Am. 2021;50(3):655-69. Epub 20210701. doi: 10.1016/j.gtc.2021.04.005. PubMed PMID: 34304793.
  134. Tornkvist NT, Aziz I, Whitehead WE, Sperber AD, Palsson OS, Hreinsson JP, Simren M, Tornblom H. Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population. United European Gastroenterol J. 2021;9(10):1178-88. Epub 20211001. doi: 10.1002/ueg2.12153. PubMed PMID: 34599559; PMCID: PMC8672084.
  135. Tse SS, Sands BE, Keefer L, Cohen BL, Maser E, Ungaro RC, Marion JF, Colombel JF, Itzkowitz SH, Gelman J, Dubinsky MC. Improved Smoking Cessation Rates in a Pharmacist-Led Program Embedded in an Inflammatory Bowel Disease Specialty Medical Home. J Pharm Pract. 2021:8971900211000682. Epub 20210408. doi: 10.1177/08971900211000682. PubMed PMID: 33827316.
  136. van Tilburg MAL, Drossman DA, Knowles SR. Psychogastroenterology: The brain-gut axis and its psychological applications. J Psychosom Res. 2021;152:110684. Epub 20211124. doi: 10.1016/j.jpsychores.2021.110684. PubMed PMID: 34847487.
  137. Vanuytsel T, Tack J, Farre R. The Role of Intestinal Permeability in Gastrointestinal Disorders and Current Methods of Evaluation. Front Nutr. 2021;8:717925. Epub 20210826. doi: 10.3389/fnut.2021.717925. PubMed PMID: 34513903; PMCID: PMC8427160.
  138. Varni JW, Shulman RJ, Self MM, Febo-Rodriguez L, Charron H, Williams K, Nurko S, Rosen RL, Chumpitazi BP, Gastroparesis Research C. PedsQL Gastroparesis Symptoms Module Domain and Item Development: Qualitative Methods. J Pediatr Gastroenterol Nutr. 2021;73(2):192-6. doi: 10.1097/MPG.0000000000003146. PubMed PMID: 33853112; PMCID: PMC8373654.
  139. Verbeure W, Geeraerts A, Huang IH, Timmermans L, Toth J, Geysen H, Cools L, Carbone F, Schol J, Devriese H, Haesaerts R, Mori H, Vanuytsel T, Tack J. The effect of an air purifier on aerosol generation measurements during clinical motility testing. Neurogastroenterol Motil. 2021:e14227. Epub 20210802. doi: 10.1111/nmo.14227. PubMed PMID: 34342092; PMCID: PMC8420584.
  140. Verbeure W, Rotondo A, Janssen P, Carbone F, Tack J. Supraphysiological effects of pancreatic polypeptide on gastric motor function and nutrient tolerance in humans. Physiol Rep. 2021;9(17):e15002. doi: 10.14814/phy2.15002. PubMed PMID: 34435472; PMCID: PMC8387790.
  141. Verbeure W, van Goor H, Mori H, van Beek AP, Tack J, van Dijk PR. The Role of Gasotransmitters in Gut Peptide Actions. Front Pharmacol. 2021;12:720703. Epub 20210720. doi: 10.3389/fphar.2021.720703. PubMed PMID: 34354597; PMCID: PMC8329365.
  142. Videlock EJ, Chang L. Latest Insights on the Pathogenesis of Irritable Bowel Syndrome. Gastroenterol Clin North Am. 2021;50(3):505-22. doi: 10.1016/j.gtc.2021.04.002. PubMed PMID: 34304785.
  143. Wauters L, Dickman R, Drug V, Mulak A, Serra J, Enck P, Tack J, Group EFC, Accarino A, Barbara G, Bor S, Coffin B, Corsetti M, De Schepper H, Dumitrascu D, Farmer A, Gourcerol G, Hauser G, Hausken T, Karamanolis G, Keszthelyi D, Malagelada C, Milosavljevic T, Muris J, O’Morain C, Papathanasopoulos A, Pohl D, Rumyantseva D, Sarnelli G, Savarino E, Schol J, Sheptulin A, Smet A, Stengel A, Storonova O, Storr M, Tornblom H, Vanuytsel T, Velosa M, Waluga M, Zarate N, Zerbib F. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia. Neurogastroenterol Motil. 2021;33(9):e14238. doi: 10.1111/nmo.14238. PubMed PMID: 34586707.
  144. Wauters L, Slaets H, De Paepe K, Ceulemans M, Wetzels S, Geboers K, Toth J, Thys W, Dybajlo R, Walgraeve D, Biessen E, Verbeke K, Tack J, Van de Wiele T, Hellings N, Vanuytsel T. Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2021;6(10):784-92. Epub 20210803. doi: 10.1016/S2468-1253(21)00226-0. PubMed PMID: 34358486.
  145. Wauters L, Tito RY, Ceulemans M, Lambaerts M, Accarie A, Rymenans L, Verspecht C, Toth J, Mols R, Augustijns P, Tack J, Vanuytsel T, Raes J. Duodenal Dysbiosis and Relation to the Efficacy of Proton Pump Inhibitors in Functional Dyspepsia. Int J Mol Sci. 2021;22(24). Epub 20211219. doi: 10.3390/ijms222413609. PubMed PMID: 34948413; PMCID: PMC8708077.
  146. Werlang ME, Sim LA, Lebow JR, Lacy BE. Assessing for Eating Disorders: A Primer for Gastroenterologists. Am J Gastroenterol. 2021;116(1):68-76. doi: 10.14309/ajg.0000000000001029. PubMed PMID: 33229986.
  147. Wise JL, Vazquez-Roque MI, McKinney CJ, Zickella MA, Crowell MD, Lacy BE. Gastric Emptying Scans: Poor Adherence to National Guidelines. Dig Dis Sci. 2021;66(9):2897-906. Epub 20200516. doi: 10.1007/s10620-020-06314-2. PubMed PMID: 32418002.
  148. Zaver HB, Ghoz H, Malviya BJ, Brahmbhatt B, Palmer WC, Lacy BE, DeVault KR, Krishna M, Bi Y. Lymphocytic Esophagitis: Assessing Risk Factors and Clinical Outcomes. Dig Dis Sci. 2021;66(11):3976-84. Epub 20201120. doi: 10.1007/s10620-020-06706-4. PubMed PMID: 33216240.
  149. Zuar LR, Chien K, Lentine J, Cooley V, Gerber LM, Ward MJ, Keefer L. Does Parenting Style Affect Adolescent IBD Transition Readiness and Self-Efficacy Scores? Children (Basel). 2021;8(5). Epub 20210504. doi: 10.3390/children8050367. PubMed PMID: 34064470; PMCID: PMC8147961.



*excludes replies/corrigendums

Back To Top